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the cone-plate method. We evaluated the analytical performance of 
the ZL 6000i to measure WBV.
Aims: We established a reference range and validated precision using 
quality control (QC) and human blood samples. Storage time and tem-
perature effects were also evaluated.
Methods: Samples were collected from 287 normal adults (162 males 
and 125 females) to establish a reference range. We evaluated total 
precision for 20 days using QC viscosity materials at shear rates of 1, 
50, and 200 s-1, and within-run precision using phlebotomy subjects 
at shear rates of 1, 5, 30, and 200 s-1. Aliquots of the phlebotomy 
samples were stored at room temperature and 5°C, respectively, for 
the stability analysis. All samples were tested at baseline (control) and 
6, 24, 48, 72, and 96 hours later to assess changes over time.
Results: Reference intervals differed between males and females 
(Table 1). 
T A B L E  1 Reference intervals for specific shear rates in health 
men and women
 Male (n = 162) Female (n = 125)
Age (years) 43 ± 10.9 46 ± 11.0
Hct (%) 46.2 ± 2.63 40.5 ± 2.29
Shear 
rates
Median 
WBV
Central 95 
percentile RI
Median 
WBV
Central 95 
percentile RI
1 21.88 16.554-
36.248
17.44 12.168-
37.303
5 9.48 7.561-12.847 7.69 6.058-13.172
30 5.35 4.311-6.369 4.51 3.582-5.915
200 3.93 3.261-4.643 3.38 2.816-3.960
The coefficients of variation (CVs) for within-run and total precision with 
QC material and human whole blood were < 7.5% at all shear rates. The 
CVs for between-day precision with QC material were < 2.5% at all shear 
rates. WBV of the samples stored at room temperature for up to 6 hours 
and at 5°C for up to 2 days did not change compared to the control.
Conclusions: We recommend that separate reference intervals be 
used for men and women. The results indicate that the ZL-6000i pro-
vides rapid, accurate and reproducible WBV data. Viscosity measure-
ments should be finished within 6 hours after sample collection, and 
samples that cannot be measured within the 6-hour window should 
be refrigerated until ready to test. 
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Background: Thrombin generation (TG) is known for more than 60 
years. Several developments have been done through the years to 
improve its usability but it remains a research use tool because of a 
lack of standardization of methods. Typical inter-day precision of TG 
assays is around 10 to 30% depending on the parameter analyzed. It 
depends on the concentration and the source of tissue factor (TF) in 
the reagent, the use of external or local normal plasma to normalize 
the results, the operator as well as the method (1-2).
Aims: ST Genesia, a new analyzer intended to measure thrombin gen-
eration in a fully automated way, was evaluated in our lab for valida-
tion purposes.
Aside from biological outcomes of our protocol in the anticoagulant 
treatment setting, the purpose of this evaluation was also to deter-
mine how precise could become TG measurement.
Methods: 41 independent runs of measurement were performed with 
the same batch of STG - DrugScreen on ST Genesia. On each run, 
3 freeze-dried samples were tested prior to testing fresh or frozen 
patient samples. 2 of these samples were internal quality control sam-
ples (hypocoagulable and normocoagulable) and 1 is intended to be 
used as reference plasma for normalizing results (2).
Results: Mean, standard deviation and coefficient of variation 
achieved are reported in table 1. 
Conclusions: Automation, enhanced control of temperature through-
out the assay and standardization of thrombin generation measure-
ment help to achieve highly reproducible results, first step to introduce 
this assay in the clinical lab. 
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 Sample 1 = STG - QualiTest Norm DS Sample 2 = STG - QualiTest Low DS Sample 3 = STG - RefPlasma DS
n=41 Mean SD CV Mean SD CV Mean SD CV
Lag time (min) 0,92 0,04 4,6% 1,18 0,05 4,1% 0,98 0,05 5,2%
Peak (nM) 501,92 16,17 3,2% 206,80 10,12 4,9% 486,25 16,50 3,4%
Time to Peak (min) 1,97 0,07 3,6% 2,32 0,10 4,3% 2,17 0,08 3,5%
ETP (nM.min) 1602,66 65,24 4,1% 522,55 20,55 3,9% 1740,53 67,63 3,9%
Velocity Index (nM/min) 718,69 55,87 7,8% 244,02 23,37 9,6% 598,74 49,27 8,2%
T A B L E  1 Performances of ST-GenesIIa on reference, hypo- and normo-coagulable plasma
